Related Experiment Video
Updated: Sep 18, 2025

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Call to action-Pediatric MASLD requires immediate attention to curb health crisis
Phillipp Hartmann1,2, Marialena Mouzaki3, Sara Hassan4
1Department of Pediatrics, University of California San Diego, La Jolla, California, USA.
Insights
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children is a growing public health crisis, increasing mortality risk. Urgent action is needed through awareness, improved care, and clinical trials to combat pediatric MASLD.
Area of Science:
- Hepatology
- Public Health
- Pediatric Gastroenterology
Background:
- Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is rising globally.
- MASLD is linked to severe childhood comorbidities and a significantly increased risk of early mortality.
- It is the primary reason for liver transplantation in young adults in the US, yet often underestimated.
Purpose of the Study:
- To raise awareness of pediatric MASLD as a critical public health issue.
- To highlight deficiencies in current screening, staging, diagnostic, and therapeutic approaches.
- To propose actionable steps to address the pediatric MASLD crisis.
Main Methods:
- Review of current screening and staging practices.
- Identification of gaps in non-invasive testing and pharmacotherapy.
- Analysis of the lack of multicenter clinical trials.
- Proposal of public health strategies and research priorities.
Main Results:
- Insufficient screening and disease staging practices are prevalent.
- A lack of accurate non-invasive tests and effective pharmacotherapy exists.
- Paucity of multicenter clinical trials hinders progress in pediatric MASLD.
Conclusions:
- Pediatric MASLD is a public health emergency requiring immediate attention.
- Comprehensive strategies including awareness campaigns, patient empowerment, and multidisciplinary care are essential.
- Public health policies and targeted clinical trials are urgently needed to control pediatric MASLD.
Abstract:
Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) has become more prevalent on a global scale over the last decades and is associated with significant comorbidities in childhood and a 40-fold higher risk of early mortality in young adulthood. MASLD has now become the leading indication for liver transplantation in young adults in the United States. However, pediatric MASLD is still perceived as an indolent condition by many patients, families, and clinicians. In this Call to Action, we aim to raise awareness of pediatric MASLD as a public health crisis. Herein, we describe insufficient screening and disease staging practices, and a lack of accurate non-invasive tests and effective pharmacotherapy, both stemming from a paucity of multicenter clinical trials in pediatric MASLD. We provide clear steps to address this public health emergency by promoting awareness campaigns, educating and empowering patients and families, addressing barriers including access to care, nutritional and exercise support programs, establishing multidisciplinary care, launching community initiatives, and conducting clinical trials in pediatric MASLD for an age-based evaluation of novel diagnostic and therapeutic options. We conclude by highlighting the urgent need for comprehensive public health policies to control the tide of pediatric MASLD and call upon stakeholders to act now.
More Related Videos
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Inborn Errors of Metabolism
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Acute Respiratory Failure-III
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Introduction Cardiac Emergencies
Prevention of Further Absorption of Poison